Neoplasms, Lung: Clinical Trials

3 trials for Neoplasms, Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 23Completed 3

Follow Neoplasms, Lung: new trials by email Literature Review of Neoplasms, Lung trials Research Report on Neoplasms, Lung

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of ESG401 in Adults With Solid Tumors
ESG401 - Neoplasms, Breast, Neoplasms, Lung
Phase 1 / Phase 2CompletedShanghai Escugen Biotechnology Co., Ltd1562021-09-142025-09-12
The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells Vaccine
cancer stem cell vaccine - Neoplasms, Lung
Phase 1 / Phase 2CompletedFuda Cancer Hospital, Guangzhou402014-03-012019-09-12
Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem Cells
cancer stem cell vaccine - Neoplasms, Lung
Phase 1 / Phase 2CompletedFuda Cancer Hospital, Guangzhou402014-03-012015-06-03

Narrower conditions

Lung Neoplasms (3)  ·  Breast Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Stomach Neoplasms (1)  ·  Urinary Bladder Neoplasms (1)

Broader conditions

Lung Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Neoplasms (3)  ·  Thoracic Neoplasms (3)  ·  Adnexal Diseases (1)  ·  Breast Diseases (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Sponsors

Fuda Cancer Hospital, Guangzhou (2)  ·  Shanghai Escugen Biotechnology Co., Ltd (1)

Countries

China (3)

Top investigators

Fei Ma (1)

Results publications

PMID 22473314, PMID 39216478, PMID 40359710